Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid.
D000418:Albumins / Q000032:analysis*; D000650:Amnion; D000653:Amniotic Fluid / Q000032:analysis*; D001663:Bilirubin / Q000032:analysis*; D001805:Blood Transfusion, Intrauterine; D004899:Erythroblastosis, Fetal / Q000175:diagnosis* / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005865:Gestational Age; D006023:Glycoproteins / Q000032:analysis*; D006418:Heme; D006461:Hemolysis; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011485:Protein Binding; D011506:Proteins / Q000032:analysis; D011677:Punctures; D012204:Rh-Hr Blood-Group System; D013053:Spectrophotometry
D000418:Albumins; D006023:Glycoproteins; D011506:Proteins; D012204:Rh-Hr Blood-Group System; D006418:Heme; D001663:Bilirubin